iPoster : A first-in-human Phase Ia dose escalation study of GDC-0077, a p110a-selective and mutant-degrading PI3K inhibitor, in patients with <i>PIK3CA</i>-mutant solid tumors

Download PDF

Add Notes

A first-in-human Phase Ia dose escalation study of GDC-0077, a p110a-selective and mutant-degrading PI3K inhibitor, in patients with <i>PIK3CA</i>-mutant solid tumors

Share ePoster

ePoster URL

ePoster URL

Sorry this feature is only available when you Sign in to iPosters.

Cancel

Remove Note

Are you sure you want to continue?

Cancel

Sorry this feature is only available when you Sign in to iPosters.